Consolidated Balance Sheet

€ million	Note	Dec. 31, 2016	Dec. 31, 2015
Non-current assets¹
Intangible assets¹	➞ 16	24,989	25,422
Property, plant and equipment¹	➞ 17	4,230	4,008
Non-current financial assets¹	➞ 18	218	130
Other non-current assets	➞ 19	131	128
Deferred tax assets	➞ 14	1,013	1,050
		30,582	30,737
Current assets¹
Inventories¹	➞ 20	2,607	2,610
Trade accounts receivable	➞ 21	2,889	2,738
Current financial assets	➞ 18	145	227
Other current assets¹	➞ 19	674	500
Income tax receivables	➞ 22	403	391
Cash and cash equivalents	➞ 23	939	832
Assets held for sale	➞ 4	12	46
		7,670	7,344
Total assets¹		38,251	38,081

Total equity	➞ 24
Equity capital		565	565
Reserves		10,362	9,679
Gains / losses recognized in equity		3,062	2,543
Equity attributable to Merck KGaA shareholders		13,989	12,787
Non-controlling interests		61	68
		14,050	12,855
Non-current liabilities¹
Provisions for pensions and other post-employment benefits	➞ 25	2,313	1,836
Other non-current provisions	➞ 26	834	855
Non-current financial liabilities	➞ 27	8,809	9,616
Other non-current liabilities	➞ 28	439	609
Deferred tax liabilities¹	➞ 14	2,720	2,926
		15,115	15,842
Current liabilities¹
Current provisions¹	➞ 26	412	536
Current financial liabilities	➞ 27	3,788	4,097
Trade accounts payable	➞ 29	2,048	1,921
Income tax liabilities	➞ 30	883	1,011
Other current liabilities	➞ 28	1,947	1,819
Liabilities directly related to assets held for sale	➞ 4	8	–
		9,086	9,384
Total equity and liabilities¹		38,251	38,081
¹ Previous year’s figures have been adjusted, see “Acquisitions, assets held for sale and disposal groups”.

Consolidated Balance Sheet

5-Year Overview

Important Contents

Services